MarginsXMarginsX
Home › Markets › Health Care › UFPT

UFP Technologies Inc. (UFPT)

UFPT trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$298.54
-2.14% on the day
Market cap
$2.3B
Mid cap
Revenue · 2025
$602.8M
+19.5% on 2024
Net income · 2025
$68.3M
11.3% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/914156/000162828026012816/0001628280-26-012816-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerUFPT on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year1993
SEC CIK0000914156
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$602.8M
Net income$68.3M
Operating income$92.3M
Net margin11.3%
Operating margin15.3%
Revenue growth+19.5%
Cash$20.3M
Total assets$655.1M
P/E (computed)33.9×
P/S (computed)3.8×

Warning signs

Cash runway
Cash-flow positive
$20.6M cash at September 30, 2026
Share count, 1 year
+0.4%
2025-11-05 to 2026-10-25 · +1.4% over 3 years
Going-concern doubt
No
10-Q filed November 6, 2026
Insider net buying, 12 months
-$14.0M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-06
Cash and burn$20.6M cash; operating cash flow $18.5M a quarter.Report 2026-09-30
Shares outstanding7,746,986 (2026-10-25); 7,712,444 a year earlier; 7,638,812 three years earlier.Cover page 2026-10-25
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorGrant Thornton LLP, Boston, Massachusetts, United StatesPCAOB Form AP 2026-03-02
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $14.0M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$172.4M$20.6M$38.5M$20.6M$96.0M$649.5M10-Q 2026-11-06
Q2 2026
2026-06-30
$174.0M$20.9M$15.6M$9.0M$117.3M$631.6M10-Q 2026-08-06
Q1 2026
2026-03-31
$154.2M$17.5M$3.2M$20.0M$137.6M$608.9M10-Q 2026-05-08
Q4 2025
2025-12-31
$148.9M$17.6M$16.8M$20.3M$135.5M$602.8M10-K 2026-02-27
Q3 2025
2025-09-30
$154.6M$16.4M$35.9M$18.2M$146.1M$598.0M10-Q 2026-11-06
Q2 2025
2025-06-30
$151.2M$17.2M$25.3M$14.9M$163.6M$588.6M10-Q 2026-08-06
Q1 2025
2025-03-31
$148.1M$17.2M$13.8M$14.0M$163.6M$547.6M10-Q 2026-05-08
Q4 2024
2024-12-31
$144.1M$16.4M$24.4M$13.4M$189.4M$504.4M10-K 2026-02-27

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest annual report10-K2026-02-27
Latest quarterly / interim10-Q2026-11-06
Latest current report8-K2026-11-03
Latest proxyDEF 14A2026-04-30

Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+0.5%
1 month+3.7%
3 months-4.6%
Year to date+37.4%
1 year+30.2%
From 52-week high-8.9%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
ATRCAtriCure Inc.$55.31-2.69%$2.8B
VVVVvVARDIS Holding AG$16.00-3.03%$2.9B
XRAYDENTSPLY SIRONA Inc.$8.95-2.35%$1.8B
LMATLeMaitre Vascular Inc.$77.01-1.63%$1.8B
IRTCiRhythm Holdings Inc.$90.83-1.18%$3.1B
INSPInspire Medical Systems Inc.$59.12-3.24%$1.7B
KMTSKestra Medical Technologies Ltd.$27.97-2.34%$1.7B
PLSEPulse Biosciences Inc Common Stock (DE)$46.36-8.09%$3.4B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier